Cargando…
Glioblastoma-Derived Small Extracellular Vesicles: Nanoparticles for Glioma Treatment
Glioblastoma (GBM), characterized by fast growth and invasion into adjacent tissue, is the most aggressive cancer of brain origin. Current protocols, which include cytotoxic chemotherapeutic agents, effectively treat localized disease; however, these aggressive therapies present side effects due to...
Autores principales: | Araujo-Abad, Salomé, Manresa-Manresa, Antonio, Rodríguez-Cañas, Enrique, Fuentes-Baile, María, García-Morales, Pilar, Mallavia, Ricardo, Saceda, Miguel, de Juan Romero, Camino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054028/ https://www.ncbi.nlm.nih.gov/pubmed/36982984 http://dx.doi.org/10.3390/ijms24065910 |
Ejemplares similares
-
CLytA-DAAO Chimeric Enzyme Bound to Magnetic Nanoparticles. A New Therapeutical Approach for Cancer Patients?
por: Fuentes-Baile, María, et al.
Publicado: (2021) -
Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3
por: Ventero, Maria Paz, et al.
Publicado: (2019) -
Cell Death Mechanisms Induced by CLytA-DAAO Chimeric Enzyme in Human Tumor Cell Lines
por: Fuentes-Baile, María, et al.
Publicado: (2020) -
Viricidal Activity of Thermoplastic Polyurethane Materials with Silver Nanoparticles
por: Díaz-Puertas, Rocío, et al.
Publicado: (2023) -
PDGFR and IGF-1R Inhibitors Induce a G2/M Arrest and Subsequent Cell Death in Human Glioblastoma Cell Lines
por: Carrasco-Garcia, Estefania, et al.
Publicado: (2018)